Important Safety Information
Who should not receive BRIUMVI?
- Do not receive BRIUMVI if you have an active hepatitis B virus (HBV) infection.
- Do not receive BRIUMVI if you have had a life-threatening allergic reaction to BRIUMVI.
|
Indication
BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
|
Click or scroll to see IMPORTANT SAFETY INFORMATION AND INDICATION
